Results 81 to 90 of about 2,106 (148)

Phenoconversion of Cytochrome P450 2D6

The Journal of Clinical Psychiatry, 2013
Berm, Elizabeth J J, Risselada, Arne J, Mulder, Hans, Hak, Eelko, Wilffert, Bob   +4 more
openaire   +4 more sources

Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review. [PDF]

Crit Care
Coste A, Aubron C, Ansart S, Roberts J, Morio F, Grégoire M.   +5 more
europepmc   +1 more source

The Syn-sleep trial protocol: detection of cutaneous phosphorylated alpha-synuclein in REM sleep behavior disorder. [PDF]

Biomark Med
Marcotte S, Levine T, Freeman R, Gibbons CH.   +3 more
europepmc   +1 more source

From Genotype to Functional Risk: A Multi-Omic Approach to Predicting Thiopurine and Methotrexate Co-Therapy-Induced Liver Injury. [PDF]

Pharmaceuticals (Basel)
Molnár D, Reznik E, Porrogi P.
europepmc   +1 more source

Epigenetic ageing and the risk of Parkinson's disease. [PDF]

J Neurol Neurosurg Psychiatry
Peng X, Flores-Torres MH, Cortese M, Peng C, Hung AY, Schwarzschild M, Ascherio A, Bjornevik K.   +7 more
europepmc   +1 more source

Pedunculopontine-thalamic cholinergic projections in rapid eye movement sleep behaviour disorder. [PDF]

NPJ Parkinsons Dis
Schumacher J, Teipel S, Storch A, Hermann W.   +3 more
europepmc   +1 more source

Gait dysfunction as an early marker of phenoconversion in REM sleep behavior disorder. [PDF]

Sci Rep
Hermann W, Sankutlu A, Nabers L, Sehr T, Trentzsch K, Donix M, Reichmann H, Brandt MD, Storch A, Ziemssen T.   +9 more
europepmc   +1 more source

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

Schizophr Bull
Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB.   +14 more
europepmc   +1 more source

Response to “Methodological Considerations on CYP2D6 Phenoconversion Due to Drug‐Drug Interaction” [PDF]

Clinical Pharmacology & Therapeutics, 2019
Kelsey, West, Andrew A, Monte
openaire   +2 more sources

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum. [PDF]

Eur J Nucl Med Mol Imaging
Arnaldi D, Mattioli P, Orso B, Raffa S, Lanfranchi F, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Montini A, Mayà G, Muñoz-Lopetegi A, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, De Verbizier D, Plazzi G, Antelmi E, Pizza F, Terzaghi M, Bossert I, Kulcsárová K, Garibotto V, Nicastro N, Lathuilière A, Bonanni L, Morbelli S, Roascio M, Arnulfo G, Pardini M.   +49 more
europepmc   +1 more source